Literature DB >> 32170402

Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas.

Cinthya J Zepeda-Mendoza1, Rachael A Vaubel1,2, Shabnam Zarei3, Cristiane M Ida1, Martin Matthews4, Sara Acree5, Aditya Raghunathan2, Caterina Giannini2, Robert B Jenkins6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32170402      PMCID： PMC8336583          DOI： 10.1007/s00401-020-02141-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  12 in total

1.  Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"?

Authors:  Jason T Huse; Eli L Diamond; Lu Wang; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2014-10-31       Impact factor: 17.088

2.  Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.

Authors:  Felix Sahm; David Reuss; Christian Koelsche; David Capper; Jens Schittenhelm; Stephanie Heim; David T W Jones; Stefan M Pfister; Christel Herold-Mende; Wolfgang Wick; Wolf Mueller; Christian Hartmann; Werner Paulus; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2014-08-21       Impact factor: 17.088

3.  cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.

Authors:  David N Louis; Caterina Giannini; David Capper; Werner Paulus; Dominique Figarella-Branger; M Beatriz Lopes; Tracy T Batchelor; J Gregory Cairncross; Martin van den Bent; Wolfgang Wick; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2018-03-01       Impact factor: 17.088

4.  cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).

Authors:  David N Louis; Pieter Wesseling; Werner Paulus; Caterina Giannini; Tracy T Batchelor; J Gregory Cairncross; David Capper; Dominique Figarella-Branger; M Beatriz Lopes; Wolfgang Wick; Martin van den Bent
Journal:  Acta Neuropathol       Date:  2018-01-25       Impact factor: 17.088

5.  Genomic aberrations in diffuse low-grade gliomas.

Authors:  Hanne-Sofie S Dahlback; Ludmila Gorunova; Petter Brandal; David Scheie; Eirik Helseth; Torstein R Meling; Sverre Heim
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

6.  Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.

Authors:  Mingqi Qu; Tommie Olofsson; Sunna Sigurdardottir; Chao You; Hannu Kalimo; Monica Nistér; Anja Smits; Zhi-Ping Ren
Journal:  Acta Neuropathol       Date:  2006-10-10       Impact factor: 17.088

7.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

Authors:  Jeanette E Eckel-Passow; Daniel H Lachance; Annette M Molinaro; Kyle M Walsh; Paul A Decker; Hugues Sicotte; Melike Pekmezci; Terri Rice; Matt L Kosel; Ivan V Smirnov; Gobinda Sarkar; Alissa A Caron; Thomas M Kollmeyer; Corinne E Praska; Anisha R Chada; Chandralekha Halder; Helen M Hansen; Lucie S McCoy; Paige M Bracci; Roxanne Marshall; Shichun Zheng; Gerald F Reis; Alexander R Pico; Brian P O'Neill; Jan C Buckner; Caterina Giannini; Jason T Huse; Arie Perry; Tarik Tihan; Mitchell S Berger; Susan M Chang; Michael D Prados; Joseph Wiemels; John K Wiencke; Margaret R Wrensch; Robert B Jenkins
Journal:  N Engl J Med       Date:  2015-06-10       Impact factor: 176.079

8.  IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.

Authors:  Romain Appay; Emeline Tabouret; Nicolas Macagno; Mehdi Touat; Catherine Carpentier; Carole Colin; François Ducray; Ahmed Idbaih; Karima Mokhtari; Emmanuelle Uro-Coste; Caroline Dehais; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 13.029

9.  A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.

Authors:  Robert B Jenkins; Yuanyuan Xiao; Hugues Sicotte; Paul A Decker; Thomas M Kollmeyer; Helen M Hansen; Matthew L Kosel; Shichun Zheng; Kyle M Walsh; Terri Rice; Paige Bracci; Lucie S McCoy; Ivan Smirnov; Joseph S Patoka; George Hsuang; Joe L Wiemels; Tarik Tihan; Alexander R Pico; Michael D Prados; Susan M Chang; Mitchel S Berger; Alissa A Caron; Stephanie R Fink; Chandralekha Halder; Amanda L Rynearson; Brooke L Fridley; Jan C Buckner; Brian P O'Neill; Caterina Giannini; Daniel H Lachance; John K Wiencke; Jeanette E Eckel-Passow; Margaret R Wrensch
Journal:  Nat Genet       Date:  2012-08-26       Impact factor: 41.307

10.  IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.

Authors:  Heather E Leeper; Alissa A Caron; Paul A Decker; Robert B Jenkins; Daniel H Lachance; Caterina Giannini
Journal:  Oncotarget       Date:  2015-10-06
View more
  3 in total

1.  Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas.

Authors:  Daniel J Brat; Kenneth Aldape; Julia A Bridge; Peter Canoll; Howard Colman; Meera R Hameed; Brent T Harris; Eyas M Hattab; Jason T Huse; Robert B Jenkins; Dolores H Lopez-Terrada; William C McDonald; Fausto J Rodriguez; Lesley H Souter; Carol Colasacco; Nicole E Thomas; Michelle Hawks Yount; Martin J van den Bent; Arie Perry
Journal:  Arch Pathol Lab Med       Date:  2022-05-01       Impact factor: 5.686

2.  Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas.

Authors:  Matthew K Ball; Thomas M Kollmeyer; Corinne E Praska; Michelle L McKenna; Caterina Giannini; Aditya Raghunathan; Mark E Jentoft; Daniel H Lachance; Benjamin R Kipp; Robert B Jenkins; Cristiane M Ida
Journal:  Neurooncol Adv       Date:  2020-08-27

3.  A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features.

Authors:  Mac Lean P Nasrallah; Arati Desai; Donald M O'Rourke; Lea F Surrey; Joel M Stein
Journal:  Acta Neuropathol Commun       Date:  2020-07-20       Impact factor: 7.801
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.